Dr. Andrew Cronyn, M.D. Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 10 Main St, Florence, MA 01062 Phone: 413-341-9400 Fax: 413-341-9421 |
News Archive
New software advances for the ATLAS® Corneal Topography System were released today by Carl Zeiss Meditec during the American Academy of Optometry meeting in Orlando, Florida. Review Software and MasterFit II™ Contact Lens Software for the ATLAS corneal topography system are designed to make clinical data and images more accessible for eye care providers, while facilitating improved eye care diagnosis and treatment solutions for patients.
SunOpta Inc. today announced that its indirect wholly-owned subsidiary SunOpta Fruit Group Inc. has completed the previously announced acquisition of the assets and business of Edner of Nevada, Inc..
The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.
Servier and Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), jointly announced today clinical data from the pivotal Phase III TAS-102 Gastric Study (TAGS) evaluating LONSURF® (trifluridine/tipiracil, TAS-102) versus placebo and best supportive care in patients with heavily pre-treated metastatic gastric cancer who have progressed or are intolerant to previous lines of therapy.
› Verified 3 days ago